EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Intrathecal Therapeutics Clinic for Administration of Tofersen in Amyotrophic Lateral Sclerosis: A Canadian Nurse Practitioner and Neurologist Collaborative Model

Gordon Jewett iD, Ellen Chan, Kris Jagt, Janet Petrillo Ballantyne, Jason Wesolosky, Tefani Perera iD, Vikram Karnik, Christopher Hahn iD, Collin Luk, Theodore Mobach

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 13.07.2026 · 1-4

DOI: 10.1017/cjn.2026.10647 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, online erschienen am 13.07.2026. Verfasst von Gordon Jewett und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neurosciences, University of Calgary Cumming School of Medicine, Canada. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tofersen is an antisense oligonucleotide administered intrathecally for amyotrophic lateral sclerosis (ALS) caused by pathogenic variants in the superoxide dismutase 1 gene. Delivering intrathecal treatments required for ongoing therapy poses logistical challenges for multidisciplinary clinics. We describe our experience establishing an efficient Canadian nurse practitioner-and neurologist-led intrathecal therapeutics clinic model, with standardized procedures and multidisciplinary monitoring. This collaborative approach has enabled efficient monthly delivery of tofersen within existing clinic infrastructure. As intrathecal therapies expand in ALS and other neurological diseases, scalable multidisciplinary models such as this may support safe and equitable care.

Schlagwörter

Stichwörter der Autor:innen

amyotrophic lateral sclerosisintrathecal therapysuperoxide dismutase 1 (SOD1)tofersen

Autor:innen und Institutionen

  • Department of Clinical Neurosciences, University of Calgary Cumming School of Medicine, Canada.
  • Hotchkiss Brain Institute, University of Calgary Cumming School of Medicine, Canada.
  • Mitchell Eye Centre, Canada.

ORCID-Profile: Gordon Jewett, Tefani Perera, Christopher Hahn

Zitieren

APA

Jewett, G., Chan, E., Jagt, K., Petrillo Ballantyne, J., Wesolosky, J., Perera, T., Karnik, V., Hahn, C., Luk, C., & Mobach, T. (2026). An Intrathecal Therapeutics Clinic for Administration of Tofersen in Amyotrophic Lateral Sclerosis: A Canadian Nurse Practitioner and Neurologist Collaborative Model. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 1-4. https://doi.org/10.1017/cjn.2026.10647

Vancouver

Jewett G, Chan E, Jagt K, Petrillo Ballantyne J, Wesolosky J, Perera T, et al. An Intrathecal Therapeutics Clinic for Administration of Tofersen in Amyotrophic Lateral Sclerosis: A Canadian Nurse Practitioner and Neurologist Collaborative Model. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 2026:1-4. doi:10.1017/cjn.2026.10647

BibTeX
@article{Jewett2026,
  author = {Jewett, Gordon and Chan, Ellen and Jagt, Kris and Petrillo Ballantyne, Janet and Wesolosky, Jason and Perera, Tefani and Karnik, Vikram and Hahn, Christopher and Luk, Collin and Mobach, Theodore},
  title = {An Intrathecal Therapeutics Clinic for Administration of Tofersen in Amyotrophic Lateral Sclerosis: A Canadian Nurse Practitioner and Neurologist Collaborative Model},
  journal = {Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques},
  year = {2026},
  pages = {1--4},
  doi = {10.1017/cjn.2026.10647}
}
Kostenlos starten →